UPDATE : Monday, June 17, 2019
[ASCO 2019]Korea expanding presence in global oncology field by Lee Han-soo, KBR correspondent 2019-06-03 11:17
[ASCO 2019]Roche CEO unveils his company’s future direction at ASCO 2019 by Lee Han-soo, KBR correspondent 2019-06-03 11:09
[ASCO 2019]'Asia vital region for Roche’ by Lee Han-soo, KBR correspondent 2019-06-03 11:01
Hanmi’s hypertension drug was effective in phase-4 study  by Jeong Sae-im 2019-05-31 16:05
Until when will Kolon keep lying about Invossa? by Jeong Sae-im 2019-05-31 14:59
Samsung BioLogics agrees to manufacture CytoDyn’s HIV drug by Jeong Sae-im 2019-05-31 14:59
Will Seoul retrieve ₩14.7 billion invested in Invossa’s R&D? by Kwak Sung-sun 2019-05-31 11:27
Supreme Court finalizes jail term to ‘Anaki’ operator by Choi Gwang-seok 2019-05-30 16:36
AbbVie’s chronic lymphocytic leukemia drug wins Korean license by Park Gi-taek 2019-05-30 15:14
Announcement of Invossa license revocation was ‘procedural breach’: Kolon by Jeong Sae-im 2019-05-30 13:28
HIV prevention pill to get insurance benefit in Korea by Kim Yun-mi 2019-05-30 13:25
Psychiatrists frustrated over alleged sexual predator’s continued medical practice  by Song Soo-youn 2019-05-29 17:17
JW Medical to launch Hitachi's ultrasound scanner device by Lee Han-soo 2019-05-29 17:06
Daiichi Sankyo to co-promote Daewoong's hypertension treatment by Lee Han-soo 2019-05-29 14:50
Regulator faces serious repercussions after Invossa debacle by Lee Hye-seon 2019-05-29 14:50
‘MDM2 gene’ may be associated with hyperprogression after immunotherapy by Kim Yun-mi 2019-05-29 12:35
YUHS transfer metastatic anticancer drug candidate technology to Repure Life Science by Lee Han-soo 2019-05-28 16:28
Invossa poses almost no safety threat: regulator by Lee Hye-seon 2019-05-28 16:02
Government to discuss gaming disorder for disease classification by Kwak Sung-sun 2019-05-28 14:44
‘Enstilum treats all psoriasis from mild to severe ones’ by Kim Yun-mi 2019-05-28 14:44
Back to Top